acyclovir
acyclovir: developed by 1 company · 1 clinical trial tracked · 1 FDA decision.
acyclovir evidence translation
What we can confirm
1 FDA record · 1 tracked trial
What it means
What to watch
Prepared research question
How could acyclovir → RDY affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Development Pipeline (1)
| Company | Phase |
|---|---|
| DR REDDYS LABORATORIES LTD (RDY) | Approved |
Clinical Trials (1)
A Multi-center, Open-label, Single-arm, Before and After Switch Study to Evaluate the Efficacy, Safety and Tolerability of Alemtuzumab in Paediatric Patients With Relapsing Remitting Multiple Sclerosis (RRMS) With Disease Activity on Prior Disease Modifying Therapy (DMT)
Primary endpoint: Brain Magnetic Resonance Imaging (MRI) Assessment: Adjusted Number of New or Enlarged T2 Lesions Per Month
FDA Decisions1 records
Frequently asked questions
Who is developing acyclovir?
acyclovir is being developed by DR REDDYS LABORATORIES LTD.
How many clinical trials involve acyclovir?
BioSniper tracks 1 clinical trial involving acyclovir.
What is acyclovir's latest FDA decision?
The most recent tracked FDA decision for acyclovir is Approval for INDICATIONS AND USAGE Herpes Zoster Infections : Acyclovir is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes : Acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox : Acyclovir is indicated for the treatment of chickenpox (varicella)., dated June 17, 2020.